Healthcare Strategic Growth Blog

Evaluating 2020 Data—Is it Useful or Not?

By Lee Ann Lambdin 

When 2020 budgets and strategic plans were set in the fall of 2019, no one could have imagined that by the following March, they’d be useless. Plans created for 2021 may be no better off, as they were established in the midst of a pandemic. How can strategic planners start again? What data and analytics should be used when 2020 trending is out of the question?

This is the first post of a series where we’ll discuss how strategic planners can regain focus, make sense of the data collected during COVID-19, and approach planning for the future. In this post, we’ll discuss how to approach 2020 data differently. In the next two posts, we’ll offer some actionable advice. 

Let’s dive in and talk about how to reconcile 2020 data and use it effectively in strategic planning.

2020 has been a year full of learning, growing, and overcoming for all of us. We hope Stratasan's Strategic Growth blog series has been a bright spot in your week, delivering insight and inspiring creativity. We uncovered innovative solutions to the healthcare revenue crisis, learned how to identify service line opportunities, discovered how new diagnosis and procedure codes are created, and much more.

As we close out the year, we thought it'd be helpful to share our five most popular blog posts of 2020. These posts received the most views and seemed to provide useful growth guidance to you, our readers. If you’re staying home for the holidays or enjoying some downtime before the new year begins, check out these posts that you may have missed or revisit your favorites for fresh insight.